May 16, 2024

US Non-Invasive Aesthetic Treatment Market Size, Share, Report by 2033

The US non-invasive aesthetic treatment market size was estimated to be around US$ 6.78 billion in 2023 and is projected to reach US$ 14.66 billion by 2033, indicating a CAGR of 7.9% from 2024 to 2033.

Non-Invasive Aesthetic Treatment Market Size in the US 2024 to 2033

Key Points

  • By procedure, the injectable segment held the largest share of the market in 2023.
  • By end-use, the hospitals and surgery centers segment held the largest share of the market in 2023.
  • By end-use, the medical spa segment is expected to capture the largest market share during the forecast period.

The market research report on the US non-invasive aesthetic treatment market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of US non-invasive aesthetic treatment products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample:

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global US non-invasive aesthetic treatment market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the US non-invasive aesthetic treatment market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of US non-invasive aesthetic treatment products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the US non-invasive aesthetic treatment market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the US non-invasive aesthetic treatment market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance.

Read Also: US Hydrogen Generation Market Size Reach USD 31.4 Bn By 2033

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

U.S. Non-Invasive Aesthetic Treatment Market Companies

  • Galderma S.A.
  • Allergen
  • El. En. SpA
  • Alma Lasers
  • Johnson & Johnson
  • Cynosure
  • Solta Medical
  • Syneron Candela
  • Lumenis
  • Merz Pharma

Segments Covered in the Report

By Procedure

  • Injectable
    • Polymer Filler
    • Collagen
    • Botulinum Toxin
    • Hyaluronic Acid
    • Calcium Hydroxylapatite
  • Skin Rejuvenation
    • Laser Skin Resurfacing
    • Chemical Peel
    • Photo-rejuvenation
  • Others
    • Hair Removal
    • Sclerotherapy
    • Non-surgical Fat Reduction
    • Cellulite Treatment

By End Use

  • Hospitals & Surgery Centers
  • Medical Spa
  • Traditional Spa
  • HCP Owned Clinic
  • Others


Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Non-Invasive Aesthetic Treatment Market 

5.1. COVID-19 Landscape: U.S. Non-Invasive Aesthetic Treatment Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: U.S Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape List of Suppliers List of Buyers

Chapter 8. U.S. Non-Invasive Aesthetic Treatment Market, By Procedure

8.1. U.S. Non-Invasive Aesthetic Treatment Market Revenue and Volume, by Procedure, 2024-2033

8.1.1. Injectable Market Revenue and Volume Forecast (2021-2033)

8.1.2. Skin Rejuvenation Market Revenue and Volume Forecast (2021-2033)

8.1.3. Others Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Non-Invasive Aesthetic Treatment Market, By End-Use

9.1. U.S. Non-Invasive Aesthetic Treatment Market Revenue and Volume, by End-Use, 2024-2033

9.1.1. Hospitals & Surgery Centers Market Revenue and Volume Forecast (2021-2033)

9.1.2. Medical Spa Market Revenue and Volume Forecast (2021-2033)

9.1.3. Traditional Spa Market Revenue and Volume Forecast (2021-2033)

9.1.4. HCP Owned Clinic Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Non-Invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast

10.1. U.S.

10.1.1. Market Revenue and Volume Forecast, by Procedure (2021-2033)

10.1.2. Market Revenue and Volume Forecast, by End-Use (2021-2033)

Chapter 11. Company Profiles

11.1. Galderma S.A.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Allergen

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. El. En. SpA

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Alma Lasers

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Johnson & Johnson

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Cynosure

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Solta Medical

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Syneron Candela

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Lumenis

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Merz Pharma

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333







I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *